上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02607 上海医药

交易中 11-27 10:29:45

12.600

-0.160

-1.25%

最高12.780	最低12.520	成交量64.97万
今开12.700	昨收12.760	日振幅2.04%
总市值466.71亿	流通市值115.79亿	总股本37.04亿
成交额821.85万	换手率0.07%	流通股本9.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02607","market":"HK","secType":"STK","nameCN":"上海医药","latestPrice":12.6,"timestamp":1732674550917,"preClose":12.76,"halted":0,"volume":649700,"delay":0,"floatShares":919000000,"shares":3704079999,"eps":1.0904176,"marketStatus":"交易中","marketStatusCode":2,"change":-0.16,"latestTime":"11-27 10:29:45","open":12.7,"high":12.78,"low":12.52,"amount":8218541,"amplitude":0.020376,"askPrice":12.64,"askSize":11000,"bidPrice":12.58,"bidSize":38800,"shortable":3,"etf":0,"ttmEps":1.1571126520402764,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1732680000000},"adr":0,"listingDate":1305820800000,"adjPreClose":12.76,"dividendRate":0.034883,"openAndCloseTimeList":[[1732671000000,1732680000000],[1732683600000,1732694400000]],"volumeRatio":0.662776,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"601607","market":"SH","secType":"STK","nameCN":"上海医药","latestPrice":22.03,"timestamp":1732674582000,"preClose":22.02,"halted":0,"volume":7941578,"delay":0,"premium":"-46.60"}},"requestUrl":"/m/hq/s/02607/wiki","defaultTab":"wiki","newsList":[{"id":"2486185960","title":"第十批国采枪声正式打响，上海医药、复星医药、齐鲁制药等药企将洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2486185960","media":"中国制药网","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486185960?lang=zh_cn&edition=full","pubTime":"2024-11-26 10:25","pubTimestamp":1732587952,"startTime":"0","endTime":"0","summary":"据悉，第十批国采共涉及263个品规，包含62个品种。业内表示，国家集采以临床需求为导向，基于充分的市场竞争，集采质优价宜的药品，保障患者用药。据悉，第十批国采，将发生重大变化，如包括B证企业数量影响最后入围企业数量、剔除价格50%降幅的保护机制、增加1.8倍熔断复活机制等新变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126103814abdf560a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126103814abdf560a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","600196","BK1515","BK1574","01477","BK1191","02196","BK1593","02607"],"gpt_icon":0},{"id":"2486067498","title":"智通港股早知道 | 科技创新和技术改造贷款加速落地 华为将举办Mate品牌盛典","url":"https://stock-news.laohu8.com/highlight/detail?id=2486067498","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486067498?lang=zh_cn&edition=full","pubTime":"2024-11-26 07:38","pubTimestamp":1732577889,"startTime":"0","endTime":"0","summary":"华为将举办Mate品牌盛典11月26日下午，华为将举办Mate品牌盛典，新品包括华为Mate70系列、折叠屏手机Mate X6、MatePad Pro 13.2英寸、华为FreeBuds Pro 4、智界新S7、尊界S800等。I48为小分子一类新药，拟用于治疗精神分裂症。截至公告日，全球未有完全相同靶点和同适应症的药品上市。公司本次申报的I48临床申请获得受理，对公司近期经营业绩不会产生重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCEI","BK1515","01478","00719","02607","07226","YANG","BK1179","BK1197","BK1191","BK1504","BK1096","01274","BK1144","HSTECH"],"gpt_icon":0},{"id":"2486709366","title":"上海医药：I048临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2486709366","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486709366?lang=zh_cn&edition=full","pubTime":"2024-11-25 18:03","pubTimestamp":1732529037,"startTime":"0","endTime":"0","summary":"南方财经11月25日电，上海医药公告，公司开发的I048临床试验申请获得国家药监局受理。I048是小分子一类新药，拟用于治疗精神分裂症。公司主导I048研发，拥有全球独占实施许可权益。截至目前，全球未有完全相同靶点和同适应症的药品上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411253249894789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1141","03347","02607","BK1197","BK1576"],"gpt_icon":0},{"id":"2486549705","title":"上海医药(02607)：I048临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2486549705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486549705?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:42","pubTimestamp":1732527778,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(02607)发布公告，近日，上海医药集团股份有限公司(以下简称“上海医药”或“公司”)开发的I048(以下简称“该项目”)临床试验申请获得国家药品监督管理局(以下简称“国家药监局”)受理。I048是小分子一类新药，拟用于治疗精神分裂症。临床前研究显示在动物疾病模型上起到显著的治疗作用。该项目由上海医药主导研发，公司拥有全球独占实施许可权益。截至本公告披露日，该项目已累计投入研发费用2223.94万元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0187","BK0184","03347","BK0188","BK1583","BK0209","BK0012","BK0028","BK0097","601607","BK0183","BK0196","BK1197","BK0175","BK0099","BK1141","BK1576","02607","BK0020"],"gpt_icon":0},{"id":"2486705786","title":"上海医药(02607.HK)旗下治疗精神分裂症新药获受理临床申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2486705786","media":"阿斯达克财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486705786?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:42","pubTimestamp":1732527720,"startTime":"0","endTime":"0","summary":"上海医药(02607.HK) 公布，公司开发的I048临床试验申请获得国家药监局受理。I048是小分子一类新药，拟用于治疗精神分裂症。公司指，临床前研究显示该药在动物疾病模型上起到显著的治疗作用。(ha/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-25 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190604131519775_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190604131519775_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1399299/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02607","BK0184","BK0012","BK0175","BK0097","BK0183","BK0196","601607","BK0188","BK0187","BK0099","BK1197","BK0209","BK0020","BK0028"],"gpt_icon":0},{"id":"2486970568","title":"上海医药最新公告：I048临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2486970568","media":"证券之星","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486970568?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:41","pubTimestamp":1732527677,"startTime":"0","endTime":"0","summary":"上海医药公告，公司开发的I048临床试验申请获得国家药监局受理。I048是小分子一类新药，拟用于治疗精神分裂症。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500024668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0184","BK0188","BK1576","BK0020","BK0196","BK1197","BK0097","BK0099","03347","BK0183","BK1141","BK0175","BK0012","BK1583","BK0028","BK0209","02607","601607"],"gpt_icon":0},{"id":"2486705542","title":"上海医药(601607.SH)：I048临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2486705542","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486705542?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:40","pubTimestamp":1732527650,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(601607.SH)发布公告，公司开发的I048临床试验申请获得国家药品监督管理局受理，I048是小分子一类新药，拟用于治疗精神分裂症。临床前研究显示在动物疾病模型上起到显著的治疗作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK0097","BK1197","BK1141","BK0209","BK0188","BK0175","BK0184","02607","BK0099","BK1576","03347","BK0020","BK0187","BK0028","601607","BK0012","BK0196","BK0183"],"gpt_icon":0},{"id":"2486705782","title":"上海医药11月25日现1笔大宗交易 成交金额516.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486705782","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486705782?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:40","pubTimestamp":1732527600,"startTime":"0","endTime":"0","summary":"　　11月25日，上海医药收涨0.37%，收盘价为21.78元，发生1笔大宗交易，合计成交量26.44万股，成交金额516.64万元。　　第1笔成交价格为19.54元，成交26.44万股，成交金额516.64万元，溢价率为-10.28%，买方营业部为华泰证券股份有限公司常州东横街证券营业部，卖方营业部为华泰证券股份有限公司常州花园街证券营业部。　　进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为516.64万元。该股近5个交易日累计上涨5.17%，主力资金合计净流入6080.72万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-25/doc-incxhqmn4920867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0099","BK0196","BK1197","BK0028","BK0020","601607","BK0183","BK0188","BK0209","BK0184","BK0187","BK0097","02607","BK0175","BK0012"],"gpt_icon":0},{"id":"2486703536","title":"11月25日上海医药现1笔折价10.28%的大宗交易 合计成交516.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486703536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486703536?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:20","pubTimestamp":1732526447,"startTime":"0","endTime":"0","summary":"证券之星消息，11月25日上海医药发生大宗交易，交易数据如下：大宗交易成交价格19.54元，相对当日收盘价折价10.28%，成交26.44万股，成交金额516.64万元，买方营业部为华泰证券股份有限公司常州东横街证券营业部，卖方营业部为华泰证券股份有限公司常州花园街证券营业部。近三个月该股共发生1笔大宗交易，合计成交2644.0手，折价成交1笔。截至2024年11月25日收盘，上海医药报收于21.78元，上涨0.37%，换手率1.53%，成交量29.64万手，成交额6.43亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500023445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1197","BK0028","BK0188","BK0209","BK0183","BK0012","BK0099","02607","BK0020","BK0175","BK0187","601607","BK0097","BK0184","BK0196"],"gpt_icon":0},{"id":"2486270816","title":"上海医药11月25日主力资金流入159万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486270816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486270816?lang=zh_cn&edition=full","pubTime":"2024-11-25 16:16","pubTimestamp":1732522608,"startTime":"0","endTime":"0","summary":"11月25日, 上海医药股价涨0.63%，报收12.74元，成交金额1.73亿元，换手率1.48%，振幅1.90%，量比3.82。上海医药今日主力资金净流入159万元，连续3日净流入，上一交易日主力净流入500万元，今日环比减少68.20%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为57.89%，平均涨幅为1.87%。该股近5个交易日下跌0.16%，主力资金累计净流入883万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入8233万元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125161742a253cf43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125161742a253cf43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2484999515","title":"上海医药11月19日主力资金流入224万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484999515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484999515?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:15","pubTimestamp":1732004158,"startTime":"0","endTime":"0","summary":"11月19日, 上海医药股价涨0.47%，报收12.78元，成交金额3592万元，换手率0.31%，振幅2.04%，量比0.49。上海医药今日主力资金净流入224万元，连续3日净流入，上一交易日主力净流入287万元，今日环比减少21.95%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为57.89%，平均涨幅为1.87%。该股近5个交易日下跌4.51%，主力资金累计净流入1213万元；近20日主力资金累计净流入8175万元，其中净流入天数为17日。该股主力净额占比0.02%，港股市场排名158/2640。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119161619a245235c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119161619a245235c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2484959431","title":"东方证券：上海医药改革创新焕发生机，目标价27.8元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484959431","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484959431?lang=zh_cn&edition=full","pubTime":"2024-11-19 10:21","pubTimestamp":1731982878,"startTime":"0","endTime":"0","summary":"财中社11月19日电东方证券发布研报称，上海医药（601607）是沪港两地上市的大型医药公司，经过二十余年的发展，医药商业与医药工业板块均处于国内领先地位。从股权结构来看，公司为国资委控股公司，实控人为上实集团，同时云南白药作为战略投资者深度参与公司的治理与运营，释放国企改革红利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411193243912679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03958","02607"],"gpt_icon":0},{"id":"2483480389","title":"“同时”举牌国药股份、上海医药，万亿新华保险疯狂“抢筹” A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483480389","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483480389?lang=zh_cn&edition=full","pubTime":"2024-11-14 21:30","pubTimestamp":1731591000,"startTime":"0","endTime":"0","summary":"通过“举牌”上海医药和国药股份，新华保险不仅获取了前期股价上涨带来的投资收益，还为未来获得稳定的高股利打下基础，同时有利于其在医疗康养产业进行全方位布局。　　新华保险开始频频“亮相”资本市场。　　11月13日晚间，上海医药、国药股份两家上市公司公告称，新华保险及其一致行动人持股比例达5%以上，触及举牌线。2024年前三季度，新华保险已出现在49家A股上市公司的前十大流通股股东之列，持仓市值达163.77亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-11-14/doc-incvzwnh4285579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0099","601336","BK0175","BK0183","BK1584","BK0196","BK0187","BK0250","SG9999006597.SGD","600511","601607","02607","BK0184","159982","01336","BK0097","BK0207","BK1184","BK0028","BK0082","BK1197","BK0012","BK0010","BK0185","399300","BK1550","BK0020","BK0188","BK0209"],"gpt_icon":0},{"id":"2483389486","title":"《股市简讯》上海医药A/H股齐劲升创逾五周新高，获股东新华保险增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2483389486","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483389486?lang=zh_cn&edition=full","pubTime":"2024-11-14 11:47","pubTimestamp":1731556076,"startTime":"0","endTime":"0","summary":"《股市简讯》上海医药A/H股齐劲升创逾五周新高，获股东新华保险增持* 上海政府旗下经营药物研发与连锁药房的上海医药A股601607.SS周四早盘最多跳涨4.7%，早市收高1.8%；其H股2607.HK一度劲扬5.7%。两者盘中均创10月8日以来新高。* 该公司此前公告称，股东新华保险1336.HK601336.SS于11月12日增持公司无限售条件流通A股和H股，权益变动后新华保险及其一致行动人合计持有上海医药5.05%股份。nL4S3MK106* 上海医药A股今年迄今劲涨27.3%，同期沪深300指数.CSI300大幅上扬19.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4S3ML09A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0099","601336","BK0196","BK0028","BK1584","BK0097","BK0012","BK0207","BK0175","02607","BK0188","BK1550","BK0187","BK0184","SG9999006597.SGD","BK1184","BK0020","601607","BK0209","01336","BK1197","BK0183"],"gpt_icon":0},{"id":"2483891672","title":"新华人寿增持上海医药股份至5.05% 看好医疗健康前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2483891672","media":"财中社","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483891672?lang=zh_cn&edition=full","pubTime":"2024-11-14 11:37","pubTimestamp":1731555435,"startTime":"0","endTime":"0","summary":"财中社11月14日电上海医药（601607/02607）发布简式权益变动报告书，信息披露义务人为新华人寿保险股份有限公司。根据报告，新华人寿于2024年11月12日通过集中竞价交易增持了上海医药的股份，包括无限售条件流通A股1000万股和H股150万股，合计占已发行普通股总股本的0.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411143239493852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2483898394","title":"港股异动 | 获新华保险举牌AH股 上海医药(02607)涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483898394","media":"智通财经","labels":["Shareholding Changes","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483898394?lang=zh_cn&edition=full","pubTime":"2024-11-14 09:39","pubTimestamp":1731548371,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，上海医药涨超4%，截至发稿，涨2.01%，报13.2港元，成交额1639.78万港元。新华保险于2024年11月12日通过二级市场集中竞价交易方式增持上海医药无限售条件流通A股9,999,836股股份和H股1,500,000股股份。本次增持后，新华保险持有上海医药A股148,951,274股，约占公司总股本的4.02%，持有H股37,895,900股，约占公司总股本的1.02%。新华资产发行的组合类资产管理产品持有上海医药A股222,300股，约占公司总股本的0.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0207","601607","BK0020","BK0196","BK0028","BK0099","BK1184","601336","02607","BK1584","BK0187","BK0184","BK0188","BK0209","01336","BK0012","BK0175","BK0097","SG9999006597.SGD","BK0183","BK1197","BK1550"],"gpt_icon":0},{"id":"2483860115","title":"A股上海医药、国药股份双双高开逾3%，两家药企均获新华保险举牌，持股比例达5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2483860115","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483860115?lang=zh_cn&edition=full","pubTime":"2024-11-14 09:33","pubTimestamp":1731548016,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0175","BK0187","BK1584","BK0188","399300","BK1184","BK0012","BK0099","BK0207","BK1197","BK0209","BK0183","BK0250","BK1550","SG9999006597.SGD","BK0097","601607","159982","01336","BK0020","BK0082","BK0196","BK0184","BK0185","601336","02607","600511","BK0010","BK0028"],"gpt_icon":0},{"id":"2483825168","title":"新华保险同日增持并举牌上海医药、国药股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483825168","media":"澎湃新闻","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483825168?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:53","pubTimestamp":1731509580,"startTime":"0","endTime":"0","summary":"新华保险  IC 资料图新华保险同日举牌两家医药上市企业。本次权益变动后，新华保险持有国药股份38244446股，约占该公司总股本的5.07%。新华保险在公告中表示，截至本报告书签署之日，暂无在未来12个月内增持或减持上海医药和国药股份的计划。在H股方面，新华保险则从今年7月以来持续买入上海医药H股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225407a2346007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225407a2346007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01336","BK1197","02607","BK1550","BK1584","BK1184"],"gpt_icon":0},{"id":"2483008265","title":"上海医药：新华保险及其一致行动人持股比例达5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483008265","media":"南方财经网","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483008265?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:09","pubTimestamp":1731496195,"startTime":"0","endTime":"0","summary":"南方财经11月13日电，上海医药公告，公司股东新华保险于11月12日通过二级市场集中竞价交易方式增持公司A股999.98万股股份和H股150万股股份。本次权益变动后，新华保险及其一致行动人合计持有上海医药A股1.49亿股和H股3789.59万股，约占公司总股本的5.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411133238607410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1584","BK1197","02607","BK1184","01336","BK1550"],"gpt_icon":0},{"id":"2483907099","title":"上海医药：新华保险及其一致行动人持股比例达到5%以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2483907099","media":"每日经济新闻","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483907099?lang=zh_cn&edition=full","pubTime":"2024-11-13 18:50","pubTimestamp":1731495026,"startTime":"0","endTime":"0","summary":"每经AI快讯，11月13日，上海医药公告，公司于2024年11月13日收到股东新华保险发来的《简式权益变动报告书》。新华保险于2024年11月12日通过二级市场集中竞价交易方式增持上海医药无限售条件流通A股9,999,836股股份和H股1,500,000股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411133238594238.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411133238594238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02607","01336","BK1184","BK1584","BK1197","BK1550"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shaphar.com.cn","stockEarnings":[{"period":"1week","weight":-0.0016},{"period":"1month","weight":0.0159},{"period":"3month","weight":0.1807},{"period":"6month","weight":0.1019},{"period":"1year","weight":0.127},{"period":"ytd","weight":0.127}],"compareEarnings":[{"period":"1week","weight":-0.0257},{"period":"1month","weight":-0.0695},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.051},{"period":"1year","weight":0.0932},{"period":"ytd","weight":0.1239}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海医药集团股份有限公司是一家主要从事医药工业、分销与零售业务的中国公司。该公司的产品包括创新药、化学药、中药和罕见病药。该公司的产品主要用于心血管系统、消化道和新陈代谢、全身性抗感染、中枢神经系统、抗肿瘤和免疫调节剂、骨骼肌肉系统和呼吸系统等领域。另外，该公司还提供医药物流和仓储服务。该公司的产品销往中国国内和海外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.004804},{"month":2,"riseRate":0.615385,"avgChangeRate":0.022499},{"month":3,"riseRate":0.615385,"avgChangeRate":0.015455},{"month":4,"riseRate":0.538462,"avgChangeRate":0.003331},{"month":5,"riseRate":0.538462,"avgChangeRate":-0.00636},{"month":6,"riseRate":0.5,"avgChangeRate":-0.012586},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.020804},{"month":8,"riseRate":0.428571,"avgChangeRate":0.005824},{"month":9,"riseRate":0.357143,"avgChangeRate":0.015401},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.020412},{"month":11,"riseRate":0.428571,"avgChangeRate":0.029784},{"month":12,"riseRate":0.615385,"avgChangeRate":-0.010289}],"exchange":"SEHK","name":"上海医药","nameEN":"SH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海医药,02607,上海医药股票,上海医药股票老虎,上海医药股票老虎国际,上海医药行情,上海医药股票行情,上海医药股价,上海医药股市,上海医药股票价格,上海医药股票交易,上海医药股票购买,上海医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}